Authors:
PENGO V
ZASSO A
BARBERO F
BIASIOLO A
RAMPAZZO P
BROCCO T
Citation: V. Pengo et al., INITIATION OF WARFARIN TREATMENT IN OUTPATIENTS WITH NONRHEUMATIC ATRIAL-FIBRILLATION - A SCHEME FOR EARLY INDICATION OF MAINTENANCE DOSE, Clinical and applied thrombosis/hemostasis, 4(4), 1998, pp. 274-276
Citation: V. Pengo et al., A RANDOMIZED TRIAL OF FIXED MINIDOSE WARFARIN IN NONRHEUMATIC ATRIAL-FIBRILLATION (MIWAF), Thrombosis research, 91(3), 1998, pp. 95-95
Citation: V. Pengo et al., DRVVT IS MORE SENSITIVE THAN KCT OR TTI FOR DETECTING LUPUS ANTICOAGULANT ACTIVITY OF ANTI-BETA-2-GLYCOPROTEIN-I AUTOANTIBODIES, Thrombosis research, 91(3), 1998, pp. 96-96
Authors:
MANOTTI C
GUAZZALOCA G
MOIA M
PENGO V
RIA L
Citation: C. Manotti et al., PERSPECTIVE STUDY ON THE PRESCRIPTION OF THE ORAL-ANTICOAGULANT-THERAPY (OAT) - USE OF A COMPUTERIZED PROGRAM - THE APROAT STUDY (AUTOMATICPRESCRIPTION OF ORAL-ANTICOAGULANT-THERAPY) - PART 1 = STABILIZATION PHASE, Thrombosis research, 91(3), 1998, pp. 165-165
Authors:
MANOTTI C
GUAZZALOCA G
MOIA M
PENGO V
RIA L
Citation: C. Manotti et al., PERSPECTIVE STUDY ON THE PRESCRIPTION OF THE ORAL-ANTICOAGULANT-THERAPY (OAT) - USE OF A COMPUTERIZED PROGRAM - THE APROAT STUDY (AUTOMATICPRESCRIPTION OF ORAL-ANTICOAGULANT-THERAPY) - PART 2 = STABILIZED PHASE, Thrombosis research, 91(3), 1998, pp. 166-166
Authors:
BIASIOLO A
RAMPAZZO P
BROCCO P
ROSATO A
BARBERO F
PENGO V
Citation: A. Biasiolo et al., [IGG ANTI-BETA-2-GLYCOPROTEIN-I BETA-2-GLYCOPROTEIN-I] IMMUNE-COMPLEXES IN PATIENTS WITH ANTIPHOSPHOLIPID (APL) SYNDROME, Thrombosis research, 91(3), 1998, pp. 243-243
Authors:
PENGO V
ZASSO A
BARBERO F
BANZATO A
NANTE G
PARISSENTI L
JOHN N
NOVENTA F
DALLAVOLTA S
Citation: V. Pengo et al., EFFECTIVENESS OF FIXED MINIDOSE WARFARIN IN THE PREVENTION OF THROMBOEMBOLISM AND VASCULAR DEATH IN NONRHEUMATIC ATRIAL-FIBRILLATION, The American journal of cardiology, 82(4), 1998, pp. 433-437
Citation: F. Barbero et al., FATAL CEREBRAL-HEMORRHAGE COMPLICATING THROMBOEMBOLIC STROKE IN A PATIENT WITH PROSTHETIC MITRAL-VALVE THROMBOSIS TREATED WITH THROMBOLYTICTHERAPY, Clinical and applied thrombosis/hemostasis, 3(4), 1997, pp. 290-293
Authors:
BARBERO F
BANZATO A
GARELLI E
ZASSO A
NOVENTA F
BIASIOLO A
BROCCO T
RAMPAZZO P
PENGO V
Citation: F. Barbero et al., A COMPARISON OF A MODERATE WITH A MODERATE-HIGH INTENSITY ORAL ANTICOAGULANT TREATMENT IN PATIENTS WITH MECHANICAL HEART-VALVE PROSTHESES, Thrombosis and haemostasis, 1997, pp. 334-334
Authors:
ZASSO A
BARBERO F
BIASIOLO A
BROCCO T
RAMPAZZO P
NANTE G
PENGO V
Citation: A. Zasso et al., A TRIAL OF FIXED MINIDOSE WARFARIN IN NONRHEUMATIC ATRIAL-FIBRILLATION - MIWAF, Thrombosis and haemostasis, 1997, pp. 338-338
Authors:
BIASIOLO A
BROCCO T
RAMPAZZO P
SARTORATO K
ZASSO A
BARBERO F
PENGO V
Citation: A. Biasiolo et al., ANTI BETA-2-GLYCOPROTEIN-I ANTIBODY ELISA TO SCREEN PATIENTS REFERREDTO A THROMBOSIS CENTER, Thrombosis and haemostasis, 1997, pp. 1361-1361
Authors:
RAMPAZZO P
BIASIOLO A
BROCCO T
SARTORATO K
BARBERO F
ZASSO A
PENGO V
Citation: P. Rampazzo et al., AUTOANTIBODIES TO CARDIOLIPIN-BINDING PLASMA-PROTEINS IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME, Thrombosis and haemostasis, 1997, pp. 2200-2200
Authors:
PENGO V
TACCOLA C
BARBERO F
ZASSO A
BIASIOLO A
BROCCO T
RAMPAZZO P
Citation: V. Pengo et al., LONG-TERM CLINICAL COURSE OF PATIENTS AFTER A FIRST EPISODE OF PULMONARY-EMBOLISM, Thrombosis and haemostasis, 1997, pp. 2904-2904
Authors:
PALARETI G
MANOTTI C
DANGELO A
PENGO V
ERBA N
MOIA M
CIAVARELLA N
DEVOTO G
BERRETTINI M
LEALI N
POGGI M
LEGNANI C
MUSOLESI S
COCCHERI S
Citation: G. Palareti et al., THROMBOTIC EVENTS DURING ORAL ANTICOAGULANT TREATMENT - RESULTS OF THE INCEPTION-COHORT, PROSPECTIVE, COLLABORATIVE ISCOAT STUDY, Thrombosis and haemostasis, 78(6), 1997, pp. 1438-1443
Authors:
PENGO V
BARBERO F
BANZATO A
GARELLI E
NOVENTA F
BIASIOLO A
ZASSO A
DALLAVOLTA S
Citation: V. Pengo et al., A COMPARISON OF A MODERATE WITH MODERATE-HIGH INTENSITY ORAL ANTICOAGULANT TREATMENT IN PATIENTS WITH MECHANICAL HEART-VALVE PROSTHESES, Thrombosis and haemostasis, 77(5), 1997, pp. 839-844
Authors:
PENGO V
BALESTRIERI G
TINCANI A
SPATOLA L
BIASIOLO A
BROCCO T
Citation: V. Pengo et al., UTILIZATION OF DILUTE RUSSELL VIPER VENOM TIME TO DETECT AUTOANTIBODIES AGAINST BETA(2)-GLYCOPROTEIN-I WHICH EXPRESS ANTICOAGULANT ACTIVITYIN THE PRESENCE BUT NOT IN THE ABSENCE OF EXOGENOUS PHOSPHOLIPIDS, Thrombosis and haemostasis, 77(1), 1997, pp. 123-126
Authors:
PENGO V
BIASIOLO A
MARSON P
DESILVESTRO G
AGOSTINI C
LIVI U
Citation: V. Pengo et al., IMMUNOSUPPRESSIVE TREATMENT IN A HEART-TRANSPLANTATION CANDIDATE WITHANTIPHOSPHOLIPID SYNDROME, Clinical rheumatology, 15(5), 1996, pp. 504-507
Authors:
AVOGARO A
CREPALDI C
MIOLA M
MARAN A
PENGO V
TIENGO A
DELPRATO S
Citation: A. Avogaro et al., HIGH BLOOD KETONE-BODY CONCENTRATION IN TYPE-2 NON-INSULIN-DEPENDENT DIABETIC-PATIENTS, Journal of endocrinological investigation, 19(2), 1996, pp. 99-105
Citation: V. Pengo et al., AUTOANTIBODIES TO PHOSPHOLIPID-BINDING PLASMA-PROTEINS IN PATIENTS WITH THROMBOSIS AND PHOSPHOLIPID-REACTIVE ANTIBODIES, Thrombosis and haemostasis, 75(5), 1996, pp. 721-724
Authors:
PALARETI G
LEALI N
COCCHERI S
POGGI M
MANOTTI C
DANGELO A
PENGO V
ERBA N
MOIA M
CIAVARELLA N
DEVOTE G
BERRETTINI M
MUSOLESI S
Citation: G. Palareti et al., BLEEDING COMPLICATIONS OF ORAL ANTICOAGULANT TREATMENT - AN INCEPTION-COHORT, PROSPECTIVE COLLABORATIVE STUDY (ISCOAT), Lancet, 348(9025), 1996, pp. 423-428
Citation: V. Pengo et al., ANTI BETA-2-GLYCOPROTEIN-I ANTIBODIES IN A PATIENT WITH CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME, Clinical rheumatology, 14(6), 1995, pp. 646-649
Authors:
PENGO V
BIASIOLO A
FIOR MG
TONETTO S
RUFFATTI A
Citation: V. Pengo et al., ANTIBODIES TO BETA-2-GLYCOPROTEIN-I IN PATIENTS WITH ANTIPHOSPHOLIPIDSYNDROME, Thrombosis and haemostasis, 73(6), 1995, pp. 1277-1277
Citation: V. Pengo et al., AUTOIMMUNE ANTIPHOSPHOLIPID ANTIBODIES ARE DIRECTED AGAINST A CRYPTICEPITOPE EXPRESSED WHEN BETA-2-GLYCOPROTEIN-I IS BOUND TO A SUITABLE SURFACE, Thrombosis and haemostasis, 73(1), 1995, pp. 29-34
Citation: V. Pengo et al., BINDING OF AUTOIMMUNE CARDIOLIPIN-REACTIVE ANTIBODIES TO HEPARIN - A MECHANISM OF THROMBOSIS, Thrombosis research, 78(5), 1995, pp. 371-378